Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade

Cecile A W Geuijen; Camilla De Nardis; David Maussang; Eric Rovers; Tristan Gallenne; Linda J A Hendriks; Therese Visser; Roy Nijhuis; Ton Logtenberg; John de Kruif; Piet Gros; Mark Throsby

doi:10.1016/j.ccell.2021.07.015

Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade

Cecile A W Geuijen, Camilla De Nardis, David Maussang, Eric Rovers, Tristan Gallenne, Linda J A Hendriks, Therese Visser, Roy Nijhuis, Ton Logtenberg, John de Kruif, Piet Gros, Mark Throsby^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1163-1164
Number of pages	2
Journal	Cancer Cell
Volume	39
Issue number	8
DOIs	https://doi.org/10.1016/j.ccell.2021.07.015
Publication status	Published - 9 Aug 2021

Access to Document

10.1016/j.ccell.2021.07.015

1-s2.0-S1535610821003949-mainFinal published version, 376 KBLicence: Taverne

2 Citations
1 Article

Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
Geuijen, C. A. W., De Nardis, C., Maussang, D., Rovers, E., Gallenne, T., Hendriks, L. J. A., Visser, T., Nijhuis, R., Logtenberg, T., de Kruif, J., Gros, P. & Throsby, M., 2018, In: Cancer Cell. 33, 5, p. 922-936.e10
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

Cite this

Geuijen, C. A. W., De Nardis, C., Maussang, D., Rovers, E., Gallenne, T., Hendriks, L. J. A., Visser, T., Nijhuis, R., Logtenberg, T., de Kruif, J., Gros, P., & Throsby, M. (2021). Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell, 39(8), 1163-1164. https://doi.org/10.1016/j.ccell.2021.07.015

@article{9720df2016c24e28ae8a85429e49d345,

title = "Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade",

author = "Geuijen, {Cecile A W} and {De Nardis}, Camilla and David Maussang and Eric Rovers and Tristan Gallenne and Hendriks, {Linda J A} and Therese Visser and Roy Nijhuis and Ton Logtenberg and {de Kruif}, John and Piet Gros and Mark Throsby",

year = "2021",

month = aug,

day = "9",

doi = "10.1016/j.ccell.2021.07.015",

language = "English",

volume = "39",

pages = "1163--1164",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "8",

}

Geuijen, CAW, De Nardis, C, Maussang, D, Rovers, E, Gallenne, T, Hendriks, LJA, Visser, T, Nijhuis, R, Logtenberg, T, de Kruif, J, Gros, P & Throsby, M 2021, 'Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade', Cancer Cell, vol. 39, no. 8, pp. 1163-1164. https://doi.org/10.1016/j.ccell.2021.07.015

Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. / Geuijen, Cecile A W; De Nardis, Camilla; Maussang, David et al.
In: Cancer Cell, Vol. 39, No. 8, 09.08.2021, p. 1163-1164.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade

AU - Geuijen, Cecile A W

AU - De Nardis, Camilla

AU - Maussang, David

AU - Rovers, Eric

AU - Gallenne, Tristan

AU - Hendriks, Linda J A

AU - Visser, Therese

AU - Nijhuis, Roy

AU - Logtenberg, Ton

AU - de Kruif, John

AU - Gros, Piet

AU - Throsby, Mark

PY - 2021/8/9

Y1 - 2021/8/9

U2 - 10.1016/j.ccell.2021.07.015

DO - 10.1016/j.ccell.2021.07.015

M3 - Comment/Letter to the editor

C2 - 34375611

SN - 1535-6108

VL - 39

SP - 1163

EP - 1164

JO - Cancer Cell

JF - Cancer Cell

IS - 8

ER -